DOCSLIB.ORG

Abstract Booklet 28Th International Conference of Alzheimer's Disease International 18

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstract Booklet 28Th International Conference of Alzheimer's Disease International 18 28th International Conference of Alzheimer’s Disease International 18 - 20 April 2013 Taipei Abstract Booklet www.adi2013.org 28th International Conference of Alzheimer’s Disease International 18 - 20 April 2013 Taipei ABSTRACT BOOKLET To search this Abstract document: Click the search button below. Enter your term in the search box. You can enter full or partial text for a speaker’s name, abstract number, category or topic. Clicking the search button will then list all successful matches for the search term, and clicking on any of the results in the list will take you immediately to the appropriate page. The search window can be shown at any time by selecting “Edit > Search” from the top fi le menu, or using the following shortcut keys: “Shift - Control - F” on a Windows operating system “Shift - Command - F” on an Apple operating system 2 www.adi2013.org PL02 Date: Thursday 18 April 2013 Sessions: Challenges for the Global Health System WORLD HEALTH ORGANIZATION MAKES DEMENTIA A PUBLIC HEALTH PRIORITY M.Wortmann1 1Executive Director of Alzheimer’s Disease International Abstract: The World Health Organization (WHO) and Alzheimer’s Disease International (ADI) have launched a report Dementia: A Public Health Priority on April 2012. The report has been made with a group of more than 30 experts from around the world and touches on aetiology, prevalence and incidence data, risk factors, dementia policies, health and social systems, care and caregivers, awareness raising and ethical issues. It concludes with a number of recommendations: with a new case of dementia every four seconds somewhere in the world, governments need to prepare and create national Alzheimer and dementia plans, stimulate dementia friendly communities, improve public and professional attitudes, improve health and social care systems, support caregivers and raise awareness about the disease and increase the priority given to dementia in the public research agenda. Dr. Margaret Chan, Director-General of the WHO says in the Foreword of the report: “The overwhelming number of people whose lives are altered by dementia, combined with the staggering economic burden on families and nations, makes dementia a public health priority. The cost of caring for people with dementia is likely to rise even faster than its prevalence, and thus it is important that societies are prepared to address the social and economic burden caused by dementia.” ADI believes that when the World Health Organization declares dementia a public health priority many countries, especially lower and middle-income countries, will be mobilised to take more action than they used to do. www.adi2013.org 3 28th International Conference of Alzheimer’s Disease International 18 - 20 April 2013 Taipei ABSTRACT BOOKLET PL04 Date: Thursday 18 April 2013 Sessions: Challenges for the Global Health System POSITIONING NON-COMMUNICABLE DISEASES (NCDS) IN THE GLOBAL HEALTH AND DEVELOPMENT AGENDA C. Adams1 Chief Executive Officer of the Union for International Cancer Control (UICC) and the Chair of the NCD Alliance Abstract: Objectives To outline the activities of the NCD Alliance has and continues to take to position NCDs in the global health and development agendas. Highlight the learning to date and the plans which are in place to include NCDs in the post 2015 discussions. I will specifically cover: - What is the NCD Alliance? - UN Summit, where did it come from, advocacy process and the results - Where we are now with follow up / WHO - Alzheimer's disease shares most risk factors with cancers, diabetes and cardiovascular disease; how can we work together to the benefit of all those affected by these diseases? - What could people take away for their own advocacy Conclusions Advocacy at the highest level demands good intel, great planning, communication and execution. References NCD Alliance materials available on www.NCDAllinace.org Disclosure of Interest: None Declared 4 www.adi2013.org PL05 Date: Thursday 18 April 2013 Sessions: Prevention and Risk Factors in Dementia THE PROJECTED EFFECT OF RISK FACTOR PREVALENCE ON ALZHEIMER’S DISEASE PREVALENCE D. E Barnes1 University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California, United States Abstract: Objectives The number of people living with Alzheimer’s disease (AD) and other forms of dementia is expected to more than triple over the next 40 years, and there are currently no disease modifying treatments or cures. However, many AD risk factors are modifiable, raising the hope that if we could lower the prevalence of AD risk factors, we could potentially lower the prevalence of AD over time. The goal of our study was to project the impact of changes in risk factor prevalence on AD prevalence worldwide. Methods We used population attributable risks (PARs) to estimate the proportion of AD cases that are potentially attributable to 7 modifiable risk factors including physical inactivity, low education, smoking, diabetes, midlife hypertension, midlife obesity, and depression. Risk factor prevalence was determined through internet searches and public databases. Relative risks were determined from the most recent and comprehensive published meta-analyses. Results Worldwide, low education contributed to the largest proportion of AD cases (nearly 1 in 5). Smoking contributed to 1 in 7 cases, while physical inactivity contributed to 1 in 8 cases and depression contributed to 1 in 10 cases. Medical conditions including diabetes, midlife hypertension and midlife obesity contributed to a smaller proportion of cases due to lower population prevalence levels. Together, the 7 modifiable risk factors examined contributed to approximately half of AD cases worldwide. If the prevalence of all 7 risk factors were 10% lower than current levels, we estimate that there would be 1.1 million fewer cases of AD. In cities such as Taipei, where smoking levels are relatively low (15%) and education levels are relatively high, it is possible that AD prevalence levels will not rise as high as current projections. Conclusions Up to half of AD cases worldwide may be attributable to modifiable risk factors. Large-scale public health interventions to encourage healthier lifestyles and public education could potentially mitigate some of the projected rise in AD prevalence over the next 40 years. References Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011; 10(9): 819-828. Disclosure of Interest: None Declared www.adi2013.org 5 28th International Conference of Alzheimer’s Disease International 18 - 20 April 2013 Taipei ABSTRACT BOOKLET PL06 Date: Thursday 18 April 2013 Sessions: Prevention and Risk Factors in Dementia RISK FACTORS AND PREVENTION IN DEMENTIA H Brodaty1,2,3 1 Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia. 2 Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia. 3 Aged Care Psychiatry, Prince of Wales Hospital, Randwick, New South Wales, Australia. Abstract: Objectives To review risk factors and preventative strategies for dementia, focusing on Alzheimer’s disease Methods Selective review of literature Results Possibly 50% of the population risk of Alzheimer’s disease can be attributed to potentially modifiable environmental and lifestyle factors including high blood pressure, obesity and high cholesterol in mid-life, diabetes (type II), high fat diets, head injury, lack of education, lack of exercise, depression, low birth weight for gestational age, social isolation and smaller head circumference. Epidemiological studies report protective effects for physical exercise, education, complex mental activity in mid-life, mental activities, fluids rich in anti-oxidants and polyphenols such as vegetables and fruit juice and wine, (green) tea, fish, anti-cholesterol drugs and hormone replacement therapy. Evidence for prevention effectiveness has been mixed. Randomised controlled trials with hormone replacement therapy, anti-inflammatory drugs, vitamin E and Ginkgo biloba have proven ineffective. Beneficial effects have been demonstrated for physical exercise, computer cognitive training, and adherence to Mediterranean diet, though not all trials are positive. There is stronger evidence that attention to vascular risk factors may prevent vascular dementia. There is no evidence for any preventative strategy for other neurodegenerative dementias such as Lewy body disease or frontotemporal dementia. Avoidance of heavy alcohol use and use of protective head gear and seat belts will reduce risk of dementia secondary to head injury. Conclusions There is no absolute prevention against Alzheimer’s disease specifically or dementia in general. Secondly, prevention often means postponement rather than elimination. Thirdly, preventative strategies may be more effective against vascular dementia. Independent replication is required before accepting reports. In any case, recommended lifestyle changes are physically beneficial and not harmful. Public campaigns to about the potential to delay onset of cognitive decline could focus on regular physical exercise, mental activity, blood pressure control, attention to diet and avoidance of obesity and type 2 diabetes. Disclosure of Interest: Consultant, advisory board member, sponsored speaker and/or investigator for Baxter, Janssen, Lilly, Lundbeck, Merck, Novartis, Pfizer, Sanofi, Servier 6 www.adi2013.org PL07 Date: Thursday 18 April 2013 Sessions: Prevention and
Load more

Recommended publications
  • Thesis and Dissertation Template
    THE IMPACT OF ENGAGEMENT WITH THE ARTS ON THE HEALTH AND WELLBEING OF HOSPITAL INPATIENTS WITH DEMENTIA _______________________ A Thesis Presented to The Royal College of Music Centre for Performance Science ______________________ In Partial Fulfilment of the Requirements for the Award of Doctor of Philosophy _______________________ by Gregory Windle April 2019 Gregory Windle 2019 Keywords: arts-in-health; dementia; hospital; wellbeing; person-centred care i ABSTRACT The global rise of dementia has provoked a multidimensional response from research, policy, and practice sectors. Care for dementia in hospital settings is of particular concern given the outsized lengths of stay and readmission rates. To respond to the resulting care needs, arts in health programmes are increasingly implemented in hospitals, with a central focus on supporting those with dementia. This PhD aimed to explore patterns of engagement with the arts and their psychosocial effects on hospital inpatients with dementia, with a particular focus on the differences in psychological impact between traditional and digital modes of engagement. The study used a sequential mixed methods design organised across three inter-related studies. Study 1, a cross-sectional study of 123 inpatients, used a questionnaire battery consisting of validated measures for loneliness, quality of life, and depression alongside questions regarding current, past-year, and life course engagement with different art forms and cultural activities. High rates of loneliness and depression were measured among participants, but current individual engagement with the arts was associated with less loneliness and increased quality of life. Notably, passive and solitary activities such as reading and watching television were associated with lower levels of loneliness.
    [Show full text]
  • Kirsch, Gesa E., Ed. Ethics and Representation In
    DOCUMENT RESUME ED 400 543 CS 215 516 AUTHOR Mortensen, Peter, Ed.; Kirsch, Gesa E., Ed. TITLE Ethics and Representation in Qualitative Studies of Literacy. INSTITUTION National Council of Teachers of English, Urbana, Ill. REPORT NO ISBN-0-8141-1596-9 PUB DATE 96 NOTE 347p.; With a collaborative foreword led by Andrea A. Lunsford and an afterword by Ruth E. Ray. AVAILABLE FROM National Council of Teachers of English, 1111 W. Kenyon Road, Urbana, IL 61801-1096 (Stock No. 15969: $21.95 members, $28.95 nonmembers). PUB TYPE Collected Works General (020) Reports Descriptive (141) EDRS PRICE MFO1 /PC14 Plus Postage. DESCRIPTORS *Case Studies; Elementary Secondary Education; *Ethics; *Ethnography; Higher Education; Participant Observation; *Qualitative Research; *Research Methodology; Research Problems; Social Influences; *Writing Research IDENTIFIERS Researcher Role ABSTRACT Reflecting on the practice of qualitative literacy research, this book presents 14 essays that address the most pressing questions faced by qualitative researchers today: how to represent others and themselves in research narratives; how to address ethical dilemmas in research-participant relationi; and how to deal with various rhetorical, institutional, and historical constraints on research. After a foreword ("Considering Research Methods in Composition and Rhetoric" by Andrea A. Lunsford and others) and an introduction ("Reflections on Methodology in Literacy Studies" by the editors), essays in the book are (1) "Seduction and Betrayal in Qualitative Research" (Thomas Newkirk); (2) "Still-Life: Representations and Silences in the. Participant-Observer Role" (Brenda Jo Brueggemann);(3) "Dealing with the Data: Ethical Issues in Case Study Research" (Cheri L. Williams);(4) "'Everything's Negotiable': Collaboration and Conflict in Composition Research" (Russel K.
    [Show full text]
  • The Effect of Art Training on Dementia Katherine Gladys Johnson A
    The Effect of Art Training on Dementia Katherine Gladys Johnson A DISSERTATION SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN PSYCHOLOGY YORK UNIVERSITY TORONTO, ONTARIO December 2018 © Katherine Johnson, 2018 Abstract The present study explores the effect of visual art training on people with dementia (PWD), utilizing a randomized control trial (RCT) design, with a structured usual activity waitlist control group, in order to investigate the effects of an eight-week visual art training program on PWD’s cognition, mood, and behaviour. Cognition was assessed with: The Backward Digit Span, measuring verbal working memory; the Body Part Pointing Test, measuring visuospatial working memory; and the Montreal Cognitive Assessment (MoCA), measuring overall cognitive function. Mood and behaviour were qualitatively assessed based on volunteer-completed observational reports. The results of the study indicate that while cognition is not significantly affected by an eight-week art training program, mood and behaviour are positively impacted. Keywords: randomized control trial, visual arts, dementia, Alzheimer’s disease, mood, behaviour, cognition ii Dedication I’m occasionally advised that it is best to remain detached as a dementia researcher, especially while working directly with patients; to remain completely separate from that which I study as well as those who I study. Beyond the reasoning that this may in some way enhance my skills as a researcher, I believe the advice also comes from a place of kindness, with the advisor sharing this thought in an attempt to somehow protect my heart and my happiness; with the reasoning that, so long as I remain detached, I won’t experience personal losses if a participant passes or moves on.
    [Show full text]
  • 1 Jess Rudolph Shogi
    Jess Rudolph Shogi – the Chess of Japan Its History and Variants When chess was first invented in India by the end of the sixth century of the current era, probably no one knew just how popular or wide spread the game would become. Only a short time into the second millennium – if not earlier – chess was being played as far as the most distant lands of the known world – the Atlantic coast of Europe and Japan. All though virtually no contact existed for centuries to come between these lands, people from both cultures were playing a game that was very similar; in Europe it was to become the chess most westerners know today and in Japan it was shogi – the Generals Game. Though shogi has many things in common with many other chess variants, those elements are not always clear because of the many differences it also has. Sadly, how the changes came about is not well known since much of the early history of shogi has been lost. In some ways the game is more similar to the Indian chaturanga than its neighboring cousin in China – xiangqi. In other ways, it’s closer to xiangqi than to any other game. In even other ways it has similarities to the Thai chess of makruk. Most likely it has elements from all these lands. It is generally believed that chess came to Japan from China through the trade routs in Korea in more than one wave, the earliest being by the end of tenth century, possibly as early as the eighth.
    [Show full text]
  • Creating Space IX Abstracts
    Creating Space IX CULTURAL HUMILITY AND CONTEMPORARY MEDICAL PRACTICE: (HOW) CAN THE HUMANITIES HELP? Abstracts Friday April 12th, 2019 THEME – RESEARCH PAPERS: DISABILITY Understanding Intolerable Suffering: Cross-Cultural Humility and End of Life Rajam Raghunathan When Bill C-14 was assented to on June 17, 2016, it extended medical assistance in dying to individuals with a "grievous and irremediable medical condition" causing them "enduring and intolerable suffering."1 Intolerable suffering is, thus, a reliable warrant by which a request for medical assistance in dying must be adjudicated. Bill C- 14 does not entirely qualify what such suffering could encompass, placing the onus on individuals to argue for their condition as intolerable, and for the adjudicating body to recognize it as such. The structure of these obligations points to an inherent unfairness which can preclude individuals from having the resources to communicate their experience. This paper explores intolerable suffering along with injustice that can arise from it. First, I articulate the necessary and sufficient conditions which must be met to assert intolerable suffering. Second, I interrogate the philosophical concept of duḥkha within Indian Buddhist epistemology as a vehicle through which to recognize the universality of suffering while maintaining its irreducible particularity. Finally, I argue that is precisely the uncertainty and heterogeneity that surround 'intolerable suffering' that fosters an ethical and epistemic obligation for ongoing critical engagement. HIV Negotiation: Using Contemporary Theory to Rethink the Biomedical HIV Risk Paradigm Rodney Rousseau HIV prevention approaches to date have emerged against a backdrop of biomedical binary categorization of bodies as either HIV-infected or HIV-uninfected.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Read Book Japanese Chess: the Game of Shogi Ebook, Epub
    JAPANESE CHESS: THE GAME OF SHOGI PDF, EPUB, EBOOK Trevor Leggett | 128 pages | 01 May 2009 | Tuttle Shokai Inc | 9784805310366 | English | Kanagawa, Japan Japanese Chess: The Game of Shogi PDF Book Memorial Verkouille A collection of 21 amateur shogi matches played in Ghent, Belgium. Retrieved 28 November In particular, the Two Pawn violation is most common illegal move played by professional players. A is the top class. This collection contains seven professional matches. Unlike in other shogi variants, in taikyoku the tengu cannot move orthogonally, and therefore can only reach half of the squares on the board. There are no discussion topics on this book yet. Visit website. The promoted silver. Brian Pagano rated it it was ok Oct 15, Checkmate by Black. Get A Copy. Kai Sanz rated it really liked it May 14, Cross Field Inc. This is a collection of amateur games that were played in the mid 's. The Oza tournament began in , but did not bestow a title until Want to Read Currently Reading Read. This article may be too long to read and navigate comfortably. White tiger. Shogi players are expected to follow etiquette in addition to rules explicitly described. The promoted lance. Illegal moves are also uncommon in professional games although this may not be true with amateur players especially beginners. Download as PDF Printable version. The Verge. It has not been shown that taikyoku shogi was ever widely played. Thus, the end of the endgame was strategically about trying to keep White's points above the point threshold. You might see something about Gene Davis Software on them, but they probably work.
    [Show full text]
  • A Companion to Digital Art WILEY BLACKWELL COMPANIONS to ART HISTORY
    A Companion to Digital Art WILEY BLACKWELL COMPANIONS TO ART HISTORY These invigorating reference volumes chart the influence of key ideas, discourses, and theories on art, and the way that it is taught, thought of, and talked about throughout the English‐speaking world. Each volume brings together a team of respected international scholars to debate the state of research within traditional subfields of art history as well as in more innovative, thematic configurations. Representing the best of the scholarship governing the field and pointing toward future trends and across disciplines, the Blackwell Companions to Art History series provides a magisterial, state‐ of‐the‐art synthesis of art history. 1 A Companion to Contemporary Art since 1945 edited by Amelia Jones 2 A Companion to Medieval Art edited by Conrad Rudolph 3 A Companion to Asian Art and Architecture edited by Rebecca M. Brown and Deborah S. Hutton 4 A Companion to Renaissance and Baroque Art edited by Babette Bohn and James M. Saslow 5 A Companion to British Art: 1600 to the Present edited by Dana Arnold and David Peters Corbett 6 A Companion to Modern African Art edited by Gitti Salami and Monica Blackmun Visonà 7 A Companion to Chinese Art edited by Martin J. Powers and Katherine R. Tsiang 8 A Companion to American Art edited by John Davis, Jennifer A. Greenhill and Jason D. LaFountain 9 A Companion to Digital Art edited by Christiane Paul 10 A Companion to Public Art edited by Cher Krause Knight and Harriet F. Senie A Companion to Digital Art Edited by Christiane Paul
    [Show full text]
  • Annual Report of the School of Medicine
    2019 Annual Report UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE REFLECTION University of Pittsburgh School of Medicine 2019 ANNUAL REPORT REFLECTION 2 A Job Well Done 6 News & Achievements 14 Education & Training 26 Research Grants of Note, 27 Publications of Note, 30 42 Community 47 Donors 62 Administration, Departments, Institutes, & Leadership COVER: Alessandro Gottardo A shooting star is said to reap good fortune — and, in reflecting upon the past two decades, Arthur S. Levine, MD, was in many ways a shooting star for the University of Pittsburgh. n past years, annual report readers have been greeted on page one with a thoughtful column by Arthur S. Levine, MD, senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of the School of Medicine. However, this year is not a typical year because Dr. Levine will step down from his leadership positions, once his successor arrives in June 2020 (see below). So, in lieu of his column, the annual report leads off with the story of Dr. Levine’s tenure, Iencapsulating quite a journey for him and for the University of Pittsburgh In addition, the report is packed with news emanating from the School of Medicine and the achievements of its students and faculty. All is worthy of reflection. Anticipation n January 7, 2020, Anantha Shekhar, MD, PhD, a nationally recognized educator, researcher, and entrepreneur with major contributions in medicine and life sciences, was named senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of the School of Medicine. His start date is June 2020.
    [Show full text]
  • Chinese Paintings in Chinese Publications, 1956-1968: an Annotated Bibliography and an Index to the Paintings
    THE UNIVERSITY OF MICHIGAN CENTER FOR CHINESE STUDIES MICHIGAN PAPERS IN CHINESE STUDIES Chang Chun-shu, James Crump, and Rhoads Murphey, Editors Ann Arbor, Michigan Chinese Paintings in Chinese Publications, 1956-1968: An Annotated Bibliography and An Index to the Paintings by E. J. Laing Michigan Papers in Chinese Studies No. 6 1969 Open access edition funded by the National Endowment for the Humanities/ Andrew W. Mellon Foundation Humanities Open Book Program. Copyright 1969 by Center for Chinese Studies The University of Michigan Ann Arbor, Michigan 48104 Printed in the United States of America ISBN 978-0-89264-124-6 (hardcover) ISBN 978-0-89264-006-5 (paper) ISBN 978-0-472-12789-4 (ebook) ISBN 978-0-472-90185-2 (open access) The text of this book is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License: https://creativecommons.org/licenses/by-nc-nd/4.0/ C ontents Foreword and Acknowledgments BIBLIOGRAPHY Notes on the Bibliography 1 Annotated Bibliography 1 INDEX Guide to the Index 33 Key to Biographical Sources 35 Abbreviations used in the Index 37 Key to Short Titles used in the Index 37 Index 41 Foreword and Acknowledgments Among the many contributions to scholarly endeavor in the field of Chinese painting made by Dr. Osvald Siren were his "Annotated Lists of Paintings and Reproductions of Paintings by Chinese Artists. TT These "Annotated Lists" were published as a part of his Chinese Painting, Leading Masters and Principles (The Ronald Press Company, New York, 19 56-58, 7 volumes). Since 19 56, the publication of reproductions of Chinese paint- ings has continued at a great pace throughout the world.
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
    A abacavir abacavirum abakaviiri abagovomab abagovomabum abagovomabi abamectin abamectinum abamektiini abametapir abametapirum abametapiiri abanoquil abanoquilum abanokiili abaperidone abaperidonum abaperidoni abarelix abarelixum abareliksi abatacept abataceptum abatasepti abciximab abciximabum absiksimabi abecarnil abecarnilum abekarniili abediterol abediterolum abediteroli abetimus abetimusum abetimuusi abexinostat abexinostatum abeksinostaatti abicipar pegol abiciparum pegolum abisipaaripegoli abiraterone abirateronum abirateroni abitesartan abitesartanum abitesartaani ablukast ablukastum ablukasti abrilumab abrilumabum abrilumabi abrineurin abrineurinum abrineuriini abunidazol abunidazolum abunidatsoli acadesine acadesinum akadesiini acamprosate acamprosatum akamprosaatti acarbose acarbosum akarboosi acebrochol acebrocholum asebrokoli aceburic acid acidum aceburicum asebuurihappo acebutolol acebutololum asebutololi acecainide acecainidum asekainidi acecarbromal acecarbromalum asekarbromaali aceclidine aceclidinum aseklidiini aceclofenac aceclofenacum aseklofenaakki acedapsone acedapsonum asedapsoni acediasulfone sodium acediasulfonum natricum asediasulfoninatrium acefluranol acefluranolum asefluranoli acefurtiamine acefurtiaminum asefurtiamiini acefylline clofibrol acefyllinum clofibrolum asefylliiniklofibroli acefylline piperazine acefyllinum piperazinum asefylliinipiperatsiini aceglatone aceglatonum aseglatoni aceglutamide aceglutamidum aseglutamidi acemannan acemannanum asemannaani acemetacin acemetacinum asemetasiini aceneuramic
    [Show full text]